R&D Partner Content 2nd Process Development for Cell Therapies The 2nd Process Development for Cell Therapies Summit Returns to Boston June 20-22
R&D Partner Content 5th Exosome Based Therapeutic Development Summit Uniting Key Biopharma and Academics Dedicated to Successfully Developing Exosome-Based Therapeutics
R&D Partner Content 6th Targeted Protein Degradation Summit Spearheading Degrader Therapeutics Towards the First Approval
R&D Partner Content 2nd Oligonucleotides CMC & Analytical Development Summit 202... Accelerate Oligonucleotide Approval with Tightened QC & Quality
R&D Partner Content Virtual workshop - Unveiling the Potency-Efficacy Connection... Join the Cell Therapy Analytical Development Searchlight network’s upcoming digital workshop: ‘Unveiling the Potency-Efficacy Connection: Integrating Functional Assay Readouts for In Vivo Insights’.
R&D Partner Content 5th RAS-Targeted Drug Development Summit The 5th RAS-Targeted Drug Development Summit returns to Boston this September.
News FDA grants three priority vouchers to psychedelics The FDA dropped a surprise Friday announcement that three more National Priority Vouchers would be given to a trio of psychedelics companies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
